Experts in cytomegalovirus in solid organ transplants discuss management strategies and emerging therapeutic options

2022-09-02

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to three experts in cytomegalovirus (CMV) to learn about the unmet needs of solid organ transplant recipients susceptible to CMV infection. Topics covered will include management challenges in solid organ transplant recipients with CMV, the evolving antiviral options for refractory and resistant CMV, and best practice for the management of refractory/resistant CMV in these patients. The experts Dr Camille Kotton – Massachusetts General Hospital, B...

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES

Listen to three experts in cytomegalovirus (CMV) to learn about the unmet needs of solid organ transplant recipients susceptible to CMV infection. Topics covered will include management challenges in solid organ transplant recipients with CMV, the evolving antiviral options for refractory and resistant CMV, and best practice for the management of refractory/resistant CMV in these patients.

The experts

Dr Camille Kotton – Massachusetts General Hospital, Boston, MA, USA
Dr Raymund Razonable – Mayo Clinic, Rochester, MN, USA
Dr Genovefa Papanicolaou – Memorial Sloan Kettering Cancer Center, New York, NY, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Takeda. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchinfectiousdiseasesime.org/eo-on-cmv-in-solid-organ-transplant-recipients/

Comments (3)